Login Register
English
0

Cart

$ 0

AACT Polyclonal Antibody

AACT Polyclonal Antibody

Views(4) Publications(0) Catalog no(ABP53122)
Datasheet Print Share Email Share
  • Specification
  • FAQ
  • Publications(0)
  • Comments(0)

Specification

Product name AACT Polyclonal Antibody
Immunogen Synthesized peptide derived from the Internal region of human AACT
Host Rabbit
Reactivity Human
Applications WB,IHC,IF,ELISA
Applications notes Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000;IHC: 1:100-1:300;ELISA 1:20000;IF 1:50-200
Clonality Polyclonal
Preparation method The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative SERPINA3; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; ACT; Cell growth-inhibiting gene 24/25 protein; Serpin A3

Product Properties

Formulation Liquid solution
Concentration 1 mg/ml
Molecular weight 46kD
Storage buffer Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
Storage instructions Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
Shipping Gel pack with blue ice.
Precautions The product listed herein is for research use only and is not intended for use in human or clinical diagnosis. Suggested applications of our products are not recommendations to use our products in violation of any patent or as a license. We cannot be responsible for patent infringements or other violations that may occur with the use of this product.

Additional Information

Background Alpha-1-antichymotrypsin encoded by SERPINA3 is a plasma protease inhibitor and member of the serine protease inhibitor class. Polymorphisms in this protein appear to be tissue specific and influence protease targeting. Variations in this protein's sequence have been implicated in Alzheimer's disease, and deficiency of this protein has been associated with liver disease. Mutations have been identified in patients with Parkinson disease and chronic obstructive pulmonary disease.
Gene ID 12
Alternative SERPINA3; AACT; GIG24; GIG25; Alpha-1-antichymotrypsin; ACT; Cell growth-inhibiting gene 24/25 protein; Serpin A3
Others AACT Polyclonal Antibody detects endogenous levels of AACT protein.
Accession P01011

Image & description

Fig.1. Western Blot analysis of 4T1 cells using AACT Polyclonal Antibody. Secondary antibody (catalog#: A21020) was diluted at 1:20000.

Fig.1. Western Blot analysis of 4T1 cells using AACT Polyclonal Antibody. Secondary antibody (catalog#: A21020) was diluted at 1:20000.

Fig.2. Immunohistochemical analysis of paraffin-embedded human-skin, antibody was diluted at 1:100.

Fig.2. Immunohistochemical analysis of paraffin-embedded human-skin, antibody was diluted at 1:100.

Fig.3. Immunohistochemical analysis of paraffin-embedded human-skin, antibody was diluted at 1:100.

Fig.3. Immunohistochemical analysis of paraffin-embedded human-skin, antibody was diluted at 1:100.

Fig.4. Immunohistochemical analysis of paraffin-embedded human-pancreas-cancer, antibody was diluted at 1:100.

Fig.4. Immunohistochemical analysis of paraffin-embedded human-pancreas-cancer, antibody was diluted at 1:100.

Fig.5. Immunohistochemical analysis of paraffin-embedded human-pancreas-cancer, antibody was diluted at 1:100.

Fig.5. Immunohistochemical analysis of paraffin-embedded human-pancreas-cancer, antibody was diluted at 1:100.

This product has been cited in0publications

Reviews

There are no reviews yet.

Be the first to review “AACT Polyclonal Antibody”